Zhejiang Taimei Medical Technology Co., Ltd. (TAIMEI TECH) disclosed a share repurchase on 23 July 2026 involving 679,600 H shares on the Hong Kong Stock Exchange.

• Scope of repurchase – Shares bought: 679,600 H shares – Percentage of outstanding H shares (ex-treasury) before the transaction: 0.34% – Price range: HKD 5.44–HKD 5.77 per share – Volume-weighted average price: HKD 5.55 – Aggregate consideration: HKD 3.77 million

• Capital structure impact – Issued shares (ex-treasury) fell to 196.50 million – Treasury shares climbed to 4.10 million – Total issued share count remained unchanged at 200.59 million

• Mandate utilisation – Shareholders authorised up to 20.02 million shares for repurchase on 23 June 2026 – Cumulative buybacks under the mandate now total 3.68 million shares, or 1.84% of the share base at the mandate date

• Regulatory timeline – Under Hong Kong Listing Rules, TAIMEI TECH faces a 30-day moratorium on new share issues or treasury-share disposals, ending 22 August 2026

The company confirmed all transactions complied with Hong Kong Main Board Rule 10.06 and related provisions.